Cargando…
Overcoming therapeutic nihilism. Breaking bad news of amyotrophic lateral sclerosis—a patient-centred perspective in rare diseases
Amyotrophic lateral sclerosis (ALS) is a rare, incurable, and fatal neurodegenerative disease with median survival time from onset to death ranging from 20 to 48 months. Breaking bad news about ALS diagnosis is a challenging task for physicians and a life-changing experience for patients. Several pr...
Autores principales: | Maksymowicz, Stanisław, Libura, Maria, Malarkiewicz, Paulina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213364/ https://www.ncbi.nlm.nih.gov/pubmed/35149928 http://dx.doi.org/10.1007/s10072-022-05931-1 |
Ejemplares similares
-
Mother’s Loneliness: Involuntary Separation of Pregnant Women in Maternity Care Settings and Its Effects on the Experience of Mothers during the COVID-19 Pandemic
por: Malarkiewicz, Paulina, et al.
Publicado: (2022) -
Breaking Bad News
por: Foster, Ryan
Publicado: (2005) -
Repeat Administration of Bone Marrow-Derived Mesenchymal Stem Cells for Treatment of Amyotrophic Lateral Sclerosis
por: Siwek, Tomasz, et al.
Publicado: (2020) -
Umbilical Cord Mesenchymal Stem Cells in Amyotrophic Lateral Sclerosis: an Original Study
por: Barczewska, Monika, et al.
Publicado: (2020) -
‘BREAKS’ Protocol for Breaking Bad News
por: Narayanan, Vijayakumar, et al.
Publicado: (2010)